Evidence map›Paper›PMID 26217791›Full record

ArticleData in brief2015

Quantitative analysis of PPT1 interactome in human neuroblastoma cells.

Enzo Scifo, Agnieszka Szwajda, Rabah Soliymani, Francesco Pezzini, Marzia Bianchi, Arvydas Dapkunas, Janusz Dębski, Kristiina Uusi-Rauva, Michał Dadlez, Anne-Claude Gingras and 5 more

Open access · goldAbstract read
In one paragraph

Article in Data in brief, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Progress toward a comprehensive brain protein interactome.Biochemical Society transactions · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 5 countries.

Enzo ScifoMeilahti Clinical Proteomics Core Facility, Institute of Biomedicine, Biochemistry and Developmental Biology, University of Helsinki, Helsinki, Finland ; Doctoral Program Brain & Mind, University of Helsinki, Helsinki, Finland.
Agnieszka SzwajdaInstitute for Molecular Medicine (FIMM), University of Helsinki, Helsinki, Finland.
Rabah SoliymaniMeilahti Clinical Proteomics Core Facility, Institute of Biomedicine, Biochemistry and Developmental Biology, University of Helsinki, Helsinki, Finland.
Francesco PezziniDepartment of Neurological and Movement Sciences, University of Verona, Verona, Italy.
Marzia BianchiDepartment of Neurological and Movement Sciences, University of Verona, Verona, Italy ; Unit for Neuromuscular and Neurodegenerative Disorders, Laboratory of Molecular Medicine, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Arvydas DapkunasMeilahti Clinical Proteomics Core Facility, Institute of Biomedicine, Biochemistry and Developmental Biology, University of Helsinki, Helsinki, Finland.
Janusz DębskiMass Spectrometry Laboratory, Department of Biophysics, Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland.
Kristiina Uusi-RauvaFolkhälsan Institute of Genetics, Helsinki, Finland ; National Institute for Health and Welfare, Public Health Genomics Unit, Helsinki, Finland.
Michał DadlezMass Spectrometry Laboratory, Department of Biophysics, Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland.
Anne-Claude GingrasCentre for Systems Biology, Samuel Lunenfeld Research Institute at Mount Sinai Hospital, Toronto, and Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
Jaana TyyneläMeilahti Clinical Proteomics Core Facility, Institute of Biomedicine, Biochemistry and Developmental Biology, University of Helsinki, Helsinki, Finland.
Alessandro SimonatiDepartment of Neurological and Movement Sciences, University of Verona, Verona, Italy.
Anu JalankoInstitute for Molecular Medicine (FIMM), University of Helsinki, Helsinki, Finland ; National Institute for Health and Welfare, Public Health Genomics Unit, Helsinki, Finland.
Marc H BaumannMeilahti Clinical Proteomics Core Facility, Institute of Biomedicine, Biochemistry and Developmental Biology, University of Helsinki, Helsinki, Finland.
Maciej LalowskiMeilahti Clinical Proteomics Core Facility, Institute of Biomedicine, Biochemistry and Developmental Biology, University of Helsinki, Helsinki, Finland ; Folkhälsan Institute of Genetics, Helsinki, Finland.
University of Helsinki · FIUniversity of Verona · ITInstitute of Biochemistry and Biophysics, Polish Academy of Sciences · PLFinnish Institute for Health and Welfare · FIMount Sinai Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations in the CLN1 gene that encodes Palmitoyl protein thioesterase 1 (PPT1) or CLN1, cause Infantile NCL (INCL, MIM#256730). PPT1 removes long fatty acid chains such as palmitate from modified cysteine residues of proteins. The data shown here result from isolated protein complexes from PPT1-expressing SH-SY5Y stable cells that were subjected to single step affinity purification coupled to mass spectrometry (AP-MS). Prior to the MS analysis, we utilised a modified filter-aided sample preparation (FASP) protocol. Based on label free quantitative analysis of the data by SAINT, 23 PPT1 interacting partners (IP) were identified. A dense connectivity in PPT1 network was further revealed by functional coupling and extended network analyses, linking it to mitochondrial ATP synthesis coupled protein transport and thioester biosynthetic process. Moreover, the terms: inhibition of organismal death, movement disorders and concentration of lipid were predicted to be altered in the PPT1 network. Data presented here are related to Scifo et al. (J. Proteomics, 123 (2015) 42-53).

Identifiers

PMID26217791
PMCPMC4510454
OpenAlexW612932688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.